BIOMAT Database Logo BIOMAT Database Logo

Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy. 1995

K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Department of Dermatology, Northwestern University Medical School, Chicago, IL 60611, USA.

BACKGROUND Acquired immune deficiency syndrome (AIDS)-related Kaposi's sarcoma (KS) is a common complication of patients infected with human immunodeficiency virus and can cause significant morbidity. Long term therapy with standard chemotherapeutic regimens has been limited by relatively short durations of response and potential toxicity. Once therapy is discontinued, the disease typically progresses. Liposome-encapsulated doxorubicin (DOX-SL) currently is being evaluated for treating patients with AIDS-related KS. Early reports suggest a high response rate and good patient tolerance permitting continued therapy for extended periods. METHODS Patients with AIDS-related KS are treated with a DOX-SL regimen every 2-3 weeks and are followed carefully for evidence of adverse treatment effects. RESULTS Two cases of hand-foot syndrome (HFS) in patients receiving DOX-SL for AIDS-related KS are reported. Tissue studies demonstrated changes consistent with a toxic effect of the drug on keratinocytes. Hand-foot syndrome was reversible once treatment stopped; however, treatment cessation resulted in primary disease recurrence. CONCLUSIONS Hand-foot syndrome can be debilitating and may be a limiting factor in the prolonged use of DOX-SL for AIDS-related KS for some patients. It is critical for clinicians using this drug to identify this side effect to limit HFS-associated morbidity.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D008081 Liposomes Artificial, single or multilaminar vesicles (made from lecithins or other lipids) that are used for the delivery of a variety of biological molecules or molecular complexes to cells, for example, drug delivery and gene transfer. They are also used to study membranes and membrane proteins. Niosomes,Transferosomes,Ultradeformable Liposomes,Liposomes, Ultra-deformable,Liposome,Liposome, Ultra-deformable,Liposome, Ultradeformable,Liposomes, Ultra deformable,Liposomes, Ultradeformable,Niosome,Transferosome,Ultra-deformable Liposome,Ultra-deformable Liposomes,Ultradeformable Liposome
D008297 Male Males
D003875 Drug Eruptions Adverse cutaneous reactions caused by ingestion, parenteral use, or local application of a drug. These may assume various morphologic patterns and produce various types of lesions. Dermatitis Medicamentosa,Dermatitis, Adverse Drug Reaction,Maculopapular Drug Eruption,Maculopapular Exanthem,Morbilliform Drug Reaction,Morbilliform Exanthem,Drug Eruption,Drug Eruption, Maculopapular,Drug Eruptions, Maculopapular,Drug Reaction, Morbilliform,Drug Reactions, Morbilliform,Eruption, Drug,Eruption, Maculopapular Drug,Eruptions, Drug,Eruptions, Maculopapular Drug,Exanthem, Maculopapular,Exanthem, Morbilliform,Exanthems, Maculopapular,Exanthems, Morbilliform,Maculopapular Drug Eruptions,Maculopapular Exanthems,Morbilliform Drug Reactions,Morbilliform Exanthems,Reaction, Morbilliform Drug,Reactions, Morbilliform Drug
D004317 Doxorubicin Antineoplastic antibiotic obtained from Streptomyces peucetius. It is a hydroxy derivative of DAUNORUBICIN. Adriamycin,Adriablastin,Adriablastine,Adriblastin,Adriblastina,Adriblastine,Adrimedac,DOXO-cell,Doxolem,Doxorubicin Hexal,Doxorubicin Hydrochloride,Doxorubicin NC,Doxorubicina Ferrer Farm,Doxorubicina Funk,Doxorubicina Tedec,Doxorubicine Baxter,Doxotec,Farmiblastina,Myocet,Onkodox,Ribodoxo,Rubex,Urokit Doxo-cell,DOXO cell,Hydrochloride, Doxorubicin,Urokit Doxo cell
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D005528 Foot The distal extremity of the leg in vertebrates, consisting of the tarsus (ANKLE); METATARSUS; phalanges; and the soft tissues surrounding these bones. Feet
D006225 Hand The distal part of the arm beyond the wrist in humans and primates, that includes the palm, fingers, and thumb. Hands
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000163 Acquired Immunodeficiency Syndrome An acquired defect of cellular immunity associated with infection by the human immunodeficiency virus (HIV), a CD4-positive T-lymphocyte count under 200 cells/microliter or less than 14% of total lymphocytes, and increased susceptibility to opportunistic infections and malignant neoplasms. Clinical manifestations also include emaciation (wasting) and dementia. These elements reflect criteria for AIDS as defined by the CDC in 1993. AIDS,Immunodeficiency Syndrome, Acquired,Immunologic Deficiency Syndrome, Acquired,Acquired Immune Deficiency Syndrome,Acquired Immuno-Deficiency Syndrome,Acquired Immuno Deficiency Syndrome,Acquired Immuno-Deficiency Syndromes,Acquired Immunodeficiency Syndromes,Immuno-Deficiency Syndrome, Acquired,Immuno-Deficiency Syndromes, Acquired,Immunodeficiency Syndromes, Acquired,Syndrome, Acquired Immuno-Deficiency,Syndrome, Acquired Immunodeficiency,Syndromes, Acquired Immuno-Deficiency,Syndromes, Acquired Immunodeficiency

Related Publications

K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Clinical studies of liposome-encapsulated doxorubicin.
January 1994, Acta oncologica (Stockholm, Sweden),
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Hand-foot syndrome related to liposomal doxorubicin.
March 2010, Oncology nursing forum,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Convection enhanced delivery of liposome encapsulated doxorubicin for brain tumour therapy.
September 2018, Journal of controlled release : official journal of the Controlled Release Society,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Palmitoyl ascorbate and doxorubicin co-encapsulated liposome for synergistic anticancer therapy.
July 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
[Hand-foot syndrome with capecitabine therapy].
June 2007, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Liposome-encapsulated doxorubicin (Doxil) and doxorubicin in the treatment of vaccine-associated sarcoma in cats.
January 2002, Journal of veterinary internal medicine,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Myocet (liposome-encapsulated doxorubicin citrate): a new approach in breast cancer therapy.
December 2002, Expert opinion on pharmacotherapy,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Local targeted therapy of liver metastasis from colon cancer by galactosylated liposome encapsulated with doxorubicin.
January 2013, PloS one,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
The hand-foot-syndrome associated with medical tumor therapy - classification and management.
September 2010, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
K B Gordon, and A Tajuddin, and J Guitart, and T M Kuzel, and L R Eramo, and J VonRoenn
Liver metastases from colorectal cancer: drug delivery with liposome-encapsulated doxorubicin.
October 1997, Radiology,
Copied contents to your clipboard!